Moderna shares plunge after leak of partial cancer vaccine data

Moderna's stock price declined Thursday following disclosure of preliminary cancer vaccine trial data. The company released complete trial results later that day. The full dataset showed results consistent with Wall Street analyst expectations prior to the release.

• CNBC — Moderna shares plunge after leak of partial cancer vaccine data

Next story